ELTX
Elicio Therapeutics, Inc.NASDAQHealthcare$10.65-0.09%ClosedMarket Cap: $195.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
99.87
P/S
0.00
EV/EBITDA
-5.00
DCF Value
$0.23
FCF Yield
-18.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-977.7%
ROA
-153.0%
ROIC
-201.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-8.8M | $-7.7M | $-0.45 | — |
| FY 2025 | $0.00 | -Infinity% | $-37.7M | $-39.6M | $-2.58 | — |
| Q3 2025 | $0.00 | -Infinity% | $-8.0M | $-10.1M | $-0.60 | — |
| Q2 2025 | $0.00 | NaN% | $-10.1M | $-10.6M | $-0.66 | — |
| Q1 2025 | $0.00 | -Infinity% | $-10.7M | $-11.2M | $-0.87 | — |
| Q4 2024 | $0.00 | -Infinity% | $-13.5M | $-14.0M | $-1.15 | — |
| FY 2024 | $0.00 | -Infinity% | $-45.0M | $-51.9M | $-4.25 | — |
| Q3 2024 | $0.00 | -Infinity% | $-10.3M | $-18.8M | $-1.39 | — |
| Q2 2024 | $0.00 | -Infinity% | $-10.9M | $-7.2M | $-0.64 | — |
| Q1 2024 | $0.00 | -Infinity% | $-10.2M | $-11.8M | $-1.15 | — |
| Q4 2023 | $0.00 | -Infinity% | $-9.4M | $-8.9M | $-0.93 | — |
| FY 2023 | $0.00 | -Infinity% | $-35.7M | $-35.2M | $-6.96 | — |